REPORT HIGHLIGHT
Cardiac Arrhythmia Monitoring Devices Market size was valued at USD 7,196.4 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.
Cardiac arrhythmia monitoring devices are medical devices designed to monitor and record the electrical activity of the heart to detect and diagnose cardiac arrhythmias. These devices play a crucial role in the management and treatment of various heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, and bradycardia. They help healthcare professionals identify irregular heart rhythms, assess their severity, and determine the appropriate treatment or intervention.
Cardiac Arrhythmia Monitoring Devices Market- Market Dynamics
The increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia is expected to propel the market demand
The increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia, is a major growth driver. Telecardiology offers cost-effective monitoring devices, with companies like Coala Life launching direct-to-patient telecardiology services. The convenience and portability of cardiac arrhythmia monitoring devices are driving market growth. Innovations such as RhythMedix's wearable novel cardiac telemetry monitor with 4G cellular connectivity for arrhythmia detection have fueled the development of similar portable cardiac monitors. However, poor adoption of telemetry technology in emerging markets and the high cost of remote cardiac arrhythmia monitoring devices are hindrances to market growth.
Cardiac Arrhythmia Monitoring Devices Market- Key Insights
As per the analysis shared by our research analyst, the global Cardiac Arrhythmia Monitoring Devices Market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)
The Cardiac Arrhythmia Monitoring Devices Market is projected to grow at a significant rate driven by the increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia.
Based on Device, the Holter monitoring devices segment was predicted to show maximum market share in the year 2022
Based on End User, the hospitals and clinics was the leading Segment in 2022
On the basis of region, North America was the leading revenue generator in 2022
Cardiac Arrhythmia Monitoring Devices Market- Segmentation Analysis:
The Global Cardiac Arrhythmia Monitoring Devices Market is segmented on the basis of Device, By End User, and Region.
Based on the Device, the market is divided into four segments: Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, Other Devices. Holter monitoring devices segment generated the highest revenue, and it is expected to maintain its leading position throughout the forecast period. Anticipated significant growth is on the horizon for the Holter monitoring devices segment as these devices have taken center stage in the market due to their ability to effectively diagnose sporadic symptoms in patients over extended durations. Moreover, they provide swifter and more convenient monitoring, resulting in heightened patient adherence and improved treatment outcomes.
The market is categorized by End User into five segments: Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others. Among these, notably, the hospitals and clinics segment took the lead of the revenue share in 2022. Furthermore, this segment is expected to experience substantial growth in the forecast period. This growth can be attributed to the rising global prevalence of cardiac arrhythmia and the increasing aging population, which is driving hospital admissions for treatment.
Cardiac Arrhythmia Monitoring Devices Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period because sophisticated healthcare infrastructure and cutting-edge cardiovascular treatments are becoming more widely used. By 2030, 12.1 million Americans, according to the Centers for Disease Control and Prevention (CDC), will suffer from atrial fibrillation (AFib). Given that atrial fibrillation (AFIb) is the most often diagnosed cardiac arrhythmia in the patient population, these figures suggest that there will likely be a rise in demand for cardiac arrhythmia monitoring devices, which will in turn fuel the expansion of the market.
Cardiac Arrhythmia Monitoring Devices Market- Competitive Landscape:
Companies in the field of cardiac arrhythmia monitoring are dedicated to advancing the technology and improving patient care. They focus on miniaturizing devices for greater patient comfort and developing implantable devices with longer lifespans. Enhancing remote monitoring capabilities is a priority, allowing for real-time data transmission to healthcare providers. Additionally, the integration of data analytics and artificial intelligence plays a crucial role in the rapid and accurate diagnosis of arrhythmias, enabling more effective patient management.
Recent Developments:
In June 2023, the first implant of its BIOMONITOR IV implanted cardiac monitor (ICM) has taken place worldwide, according to BIOTRONIK, a pioneer in implantable medical device technology. Luigi Di Biase, MD, PhD, Director of Arrhythmia Services, Section Head of Electrophysiology, and Professor of Medicine at Montefiore Einstein in the Bronx, New York, performed the procedure. The next development in heart monitoring technology is this first implant.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET KEY PLAYERS
- ACSDiagnostics
- AliveCor Inc.
- Abbott Laboratories
- Biotronik
- GE Healthcare
- iRhythm Technologies Inc
- Medi-Lynx
- Medtronic PLC
- Koninklijke Philips NV
- Welch Allyn
- Spacelabs Healthcare Inc
- Fukuda Denshi
GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE
- Event Monitoring Devices
- Continuous Rhythm Monitoring Devices
- Holter Monitoring Devices
- Other Devices
GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER
- Hospitals and Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Homecare Settings
- Others
GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA